COVID-19 Vaccines and Heavy Menstrual Bleeding: The Impact of Media Attention on Reporting to EudraVigilance
Open Access
- 12 April 2024
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 47 (8) , 783-798
Abstract
Background and Objective During the COVID-19 vaccination campaign, over 34,000 reports of heavy menstrual bleeding following the administration of COVID-19 vaccines originating in the Economic European Area were submitted to EudraVigilance, the European Union database of suspected adverse drug reactions. More than 90% of these reports were sent by consumers while the remaining by healthcare professionals. Public concerns regarding menstruation disorders in COVID-19 vaccinees were also covered by the media. We investigated the impact of media attention on the reporting trends of heavy menstrual bleeding to EudraVigilance. Methods We used media outlets published in the Economic European Area on menstrual disorders and COVID-19 vaccines from the beginning of the vaccination campaign in the Economic European Area (1 January, 2021) until December 2022 (i.e., after the regulatory request to add the adverse event to the product information) and spontaneous reports from EudraVigilance. Results We found that the publication of safety updates from regulatory authorities and subsequent coverage in media outlets preceded increased reporting to EudraVigilance. Furthermore, the heavy menstrual bleeding reported in the cases occurred several weeks or months earlier and were not submitted to the respective date. The analysis suggests that the spikes in reporting of heavy menstrual bleeding were to some extent influenced by media coverage in some countries. Conclusions Consumer reporting to the European Union spontaneous data collection system, EudraVigilance, was of high value for regulatory safety reviews, albeit the reporting behaviours were not free of the influence of the media. These sources of information can be investigated to understand the context of safety concerns of public health interest.Keywords
This publication has 12 references indexed in Scilit:
- Safety Monitoring of COVID‐19 Vaccines: Perspective from the European Medicines AgencyClinical Pharmacology & Therapeutics, 2023
- Impact of media coverage on side effect reports from the COVID-19 vaccineJournal of Psychosomatic Research, 2022
- Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive studyFrontiers in Pharmacology, 2022
- The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse ReactionsDrug Safety, 2021
- Existence of Notoriety Bias in FDA Adverse Event Reporting System Database and Its Impact on Signal StrengthHospital Pharmacy, 2019
- Bad news: The influence of news coverage and Google searches on Gardasil adverse event reportingVaccine, 2017
- Patient Reporting in the EU: Analysis of EudraVigilance DataDrug Safety, 2017
- The Role of Media and the Internet on Vaccine Adverse Event Reporting: A Case Study of Human Papillomavirus VaccinationJournal of Adolescent Health, 2014
- Impact of television coverage on the number and type of symptoms reported during a health scare: a retrospective pre–post observational studyBMJ Open, 2012
- Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statinsPharmacoepidemiology and Drug Safety, 2009